Search
Bay Area based Universal Brain has developed a wearable dry EEG (now 501(k) cleared by FDA) that aims to measure task based biomarkers of brain function for psychiatry
Founder and CEO Kazu Okuda describes the effort to make this technology a reality. He says they have already published evidence that the device can measure the onset of and predict the remission of depression, and the ultimate goal is to get it to a place one day where it can help predict response to therapies.
11 hours ago
.png){kind=logo}